Athletes Foot Solution/ Drops
NDC 83837-002
Product Information
Athletes Foot (tolnaftate) is a OTC MONOGRAPH DRUG-approved product labeled by Imperial Feet B.v.. Tolnaftate is used to treat skin infections such as athlete's foot, jock itch, and ringworm. It is supplied as a solution/ drops for topical administration. This product entry covers the primary NDC 83837-002 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 83837-002?
What are the uses of this product?
What are Active Ingredients of this product?
- TOLNAFTATE 1 g/100mL - A synthetic antifungal agent.
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- TOLNAFTATE (UNII: 06KB629TKV)
- TOLNAFTATE (UNII: 06KB629TKV) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- CALENDULA OFFICINALIS FLOWER (UNII: P0M7O4Y7YD)
- CHLORPHENESIN (UNII: I670DAL4SZ)
- PIROCTONE OLAMINE (UNII: A4V5C6R9FB)
- ALMOND OIL (UNII: 66YXD4DKO9)
- POLYOXYL 40 HYDROGENATED CASTOR OIL (UNII: 7YC686GQ8F)
- WATER (UNII: 059QF0KO0R)
- SQUALENE (UNII: 7QWM220FJH)
- METHYL GLUCETH-20 (UNII: J3QD0LD11P)
- .ALPHA.-BISABOLOL, (+)- (UNII: 105S6I733Z)
- PHENOXYETHANOL (UNII: HIE492ZZ3T)
- POLYSORBATE 20 (UNII: 7T1F30V5YH)
- CHAMOMILE FLOWER OIL (UNII: 60F80Z61A9)
- POLYETHYLENE GLYCOL 400 (UNII: B697894SGQ)
- GLYCERIN (UNII: PDC6A3C0OX)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 313423 - tolnaftate 1 % Topical Solution
- RxCUI: 313423 - tolnaftate 10 MG/ML Topical Solution
* Please review the full disclaimer at the bottom of this page.